id	sid	tid	token	lemma	pos
dpc-2637	1	1	dermatology	dermatology	NOUN
dpc-2637	1	2	:	:	PUNCT
dpc-2637	1	3	practical	practical	ADJ
dpc-2637	1	4	and	and	CCONJ
dpc-2637	1	5	conceptual	conceptual	ADJ
dpc-2637	1	6	commentary	commentary	NOUN
dpc-2637	1	7	|	|	ADV
dpc-2637	1	8	dermatol	dermatol	ADJ
dpc-2637	1	9	pract	pract	NOUN
dpc-2637	1	10	concept	concept	NOUN
dpc-2637	1	11	.	.	PUNCT
dpc-2637	2	1	2023;13(1):e2023063	2023;13(1):e2023063	NUM
dpc-2637	2	2	1	1	NUM
dpc-2637	2	3	treatment	treatment	NOUN
dpc-2637	2	4	of	of	ADP
dpc-2637	2	5	diabetes	diabetes	NOUN
dpc-2637	2	6	in	in	ADP
dpc-2637	2	7	bullous	bullous	ADJ
dpc-2637	2	8	pemphigoid	pemphigoid	ADJ
dpc-2637	2	9	patients	patient	NOUN
dpc-2637	2	10	:	:	PUNCT
dpc-2637	2	11	where	where	SCONJ
dpc-2637	2	12	do	do	AUX
dpc-2637	2	13	we	we	PRON
dpc-2637	2	14	stand	stand	VERB
dpc-2637	2	15	?	?	PUNCT
dpc-2637	3	1	maria	maria	PROPN
dpc-2637	3	2	inês	inês	PROPN
dpc-2637	3	3	alexandre1	alexandre1	PROPN
dpc-2637	3	4	,	,	PUNCT
dpc-2637	3	5	pedro	pedro	PROPN
dpc-2637	3	6	miguel	miguel	PROPN
dpc-2637	3	7	garrido2	garrido2	PROPN
dpc-2637	3	8	,	,	PUNCT
dpc-2637	3	9	paulo	paulo	PROPN
dpc-2637	3	10	filipe2,3,4	filipe2,3,4	NOUN
dpc-2637	3	11	1	1	NUM
dpc-2637	3	12	endocrinology	endocrinology	NOUN
dpc-2637	3	13	department	department	NOUN
dpc-2637	3	14	,	,	PUNCT
dpc-2637	3	15	hospital	hospital	NOUN
dpc-2637	3	16	de	de	X
dpc-2637	3	17	santa	santa	PROPN
dpc-2637	3	18	maria	maria	PROPN
dpc-2637	3	19	,	,	PUNCT
dpc-2637	3	20	centro	centro	PROPN
dpc-2637	3	21	hospitalar	hospitalar	PROPN
dpc-2637	3	22	universitário	universitário	PROPN
dpc-2637	3	23	de	de	PROPN
dpc-2637	3	24	lisboa	lisboa	PROPN
dpc-2637	3	25	norte	norte	PROPN
dpc-2637	3	26	,	,	PUNCT
dpc-2637	3	27	lisbon	lisbon	PROPN
dpc-2637	3	28	,	,	PUNCT
dpc-2637	3	29	portugal	portugal	PROPN
dpc-2637	3	30	2	2	NUM
dpc-2637	3	31	dermatology	dermatology	NOUN
dpc-2637	3	32	department	department	NOUN
dpc-2637	3	33	,	,	PUNCT
dpc-2637	3	34	hospital	hospital	NOUN
dpc-2637	3	35	de	de	X
dpc-2637	3	36	santa	santa	PROPN
dpc-2637	3	37	maria	maria	PROPN
dpc-2637	3	38	,	,	PUNCT
dpc-2637	3	39	centro	centro	PROPN
dpc-2637	3	40	hospitalar	hospitalar	PROPN
dpc-2637	3	41	universitário	universitário	PROPN
dpc-2637	3	42	de	de	PROPN
dpc-2637	3	43	lisboa	lisboa	PROPN
dpc-2637	3	44	norte	norte	PROPN
dpc-2637	3	45	,	,	PUNCT
dpc-2637	3	46	lisbon	lisbon	PROPN
dpc-2637	3	47	,	,	PUNCT
dpc-2637	3	48	portugal	portugal	PROPN
dpc-2637	3	49	3	3	NUM
dpc-2637	3	50	university	university	NOUN
dpc-2637	3	51	dermatology	dermatology	NOUN
dpc-2637	3	52	clinic	clinic	NOUN
dpc-2637	3	53	,	,	PUNCT
dpc-2637	3	54	faculty	faculty	NOUN
dpc-2637	3	55	of	of	ADP
dpc-2637	3	56	medicine	medicine	NOUN
dpc-2637	3	57	,	,	PUNCT
dpc-2637	3	58	university	university	NOUN
dpc-2637	3	59	of	of	ADP
dpc-2637	3	60	lisbon	lisbon	PROPN
dpc-2637	3	61	,	,	PUNCT
dpc-2637	3	62	lisbon	lisbon	PROPN
dpc-2637	3	63	,	,	PUNCT
dpc-2637	3	64	portugal	portugal	PROPN
dpc-2637	3	65	4	4	NUM
dpc-2637	3	66	dermatology	dermatology	NOUN
dpc-2637	3	67	research	research	NOUN
dpc-2637	3	68	unit	unit	NOUN
dpc-2637	3	69	,	,	PUNCT
dpc-2637	3	70	instituto	instituto	PROPN
dpc-2637	3	71	de	de	PROPN
dpc-2637	3	72	medicina	medicina	PROPN
dpc-2637	3	73	molecular	molecular	NOUN
dpc-2637	3	74	,	,	PUNCT
dpc-2637	3	75	university	university	NOUN
dpc-2637	3	76	of	of	ADP
dpc-2637	3	77	lisbon	lisbon	PROPN
dpc-2637	3	78	,	,	PUNCT
dpc-2637	3	79	lisbon	lisbon	PROPN
dpc-2637	3	80	,	,	PUNCT
dpc-2637	3	81	portugal	portugal	PROPN
dpc-2637	3	82	citation	citation	NOUN
dpc-2637	3	83	:	:	PUNCT
dpc-2637	3	84	alexandre	alexandre	PROPN
dpc-2637	3	85	mi	mi	PROPN
dpc-2637	3	86	,	,	PUNCT
dpc-2637	3	87	garrido	garrido	PROPN
dpc-2637	3	88	pm	pm	PROPN
dpc-2637	3	89	,	,	PUNCT
dpc-2637	3	90	filipe	filipe	PROPN
dpc-2637	3	91	p.	p.	NOUN
dpc-2637	3	92	treatment	treatment	NOUN
dpc-2637	3	93	of	of	ADP
dpc-2637	3	94	diabetes	diabetes	NOUN
dpc-2637	3	95	in	in	ADP
dpc-2637	3	96	bullous	bullous	ADJ
dpc-2637	3	97	pemphigoid	pemphigoid	ADJ
dpc-2637	3	98	patients	patient	NOUN
dpc-2637	3	99	:	:	PUNCT
dpc-2637	3	100	where	where	SCONJ
dpc-2637	3	101	do	do	AUX
dpc-2637	3	102	we	we	PRON
dpc-2637	3	103	stand	stand	VERB
dpc-2637	3	104	?	?	PUNCT
dpc-2637	4	1	dermatol	dermatol	NOUN
dpc-2637	4	2	pract	pract	PROPN
dpc-2637	4	3	concept	concept	NOUN
dpc-2637	4	4	.	.	PUNCT
dpc-2637	5	1	2023;13(1):e2023063	2023;13(1):e2023063	NUM
dpc-2637	5	2	.	.	PUNCT
dpc-2637	5	3	doi	doi	PROPN
dpc-2637	5	4	:	:	PUNCT
dpc-2637	5	5	https://doi.org/10.5826/dpc.1301a63	https://doi.org/10.5826/dpc.1301a63	PROPN
dpc-2637	5	6	accepted	accept	VERB
dpc-2637	5	7	:	:	PUNCT
dpc-2637	5	8	april	april	PROPN
dpc-2637	5	9	13	13	NUM
dpc-2637	5	10	,	,	PUNCT
dpc-2637	5	11	2022	2022	NUM
dpc-2637	5	12	;	;	PUNCT
dpc-2637	5	13	published	publish	VERB
dpc-2637	5	14	:	:	PUNCT
dpc-2637	5	15	january	january	NOUN
dpc-2637	5	16	2023	2023	NUM
dpc-2637	6	1	copyright	copyright	NOUN
dpc-2637	6	2	:	:	PUNCT
dpc-2637	6	3	©	©	PROPN
dpc-2637	6	4	2023	2023	NUM
dpc-2637	6	5	alexandre	alexandre	NOUN
dpc-2637	6	6	et	et	PROPN
dpc-2637	6	7	al	al	PROPN
dpc-2637	6	8	.	.	PUNCT
dpc-2637	7	1	this	this	PRON
dpc-2637	7	2	is	be	AUX
dpc-2637	7	3	an	an	DET
dpc-2637	7	4	open	open	ADJ
dpc-2637	7	5	-	-	PUNCT
dpc-2637	7	6	access	access	NOUN
dpc-2637	7	7	article	article	NOUN
dpc-2637	7	8	distributed	distribute	VERB
dpc-2637	7	9	under	under	ADP
dpc-2637	7	10	the	the	DET
dpc-2637	7	11	terms	term	NOUN
dpc-2637	7	12	of	of	ADP
dpc-2637	7	13	the	the	DET
dpc-2637	7	14	creative	creative	ADJ
dpc-2637	7	15	commons	common	NOUN
dpc-2637	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-2637	7	17	license	license	NOUN
dpc-2637	7	18	(	(	PUNCT
dpc-2637	7	19	by	by	ADP
dpc-2637	7	20	-	-	PUNCT
dpc-2637	7	21	nc-4.0	nc-4.0	NOUN
dpc-2637	7	22	)	)	PUNCT
dpc-2637	7	23	,	,	PUNCT
dpc-2637	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-2637	7	25	,	,	PUNCT
dpc-2637	7	26	which	which	PRON
dpc-2637	7	27	permits	permit	VERB
dpc-2637	7	28	unrestricted	unrestricted	ADJ
dpc-2637	7	29	noncommercial	noncommercial	ADJ
dpc-2637	7	30	use	use	NOUN
dpc-2637	7	31	,	,	PUNCT
dpc-2637	7	32	distribution	distribution	NOUN
dpc-2637	7	33	,	,	PUNCT
dpc-2637	7	34	and	and	CCONJ
dpc-2637	7	35	reproduction	reproduction	NOUN
dpc-2637	7	36	in	in	ADP
dpc-2637	7	37	any	any	DET
dpc-2637	7	38	medium	medium	NOUN
dpc-2637	7	39	,	,	PUNCT
dpc-2637	7	40	provided	provide	VERB
dpc-2637	7	41	the	the	DET
dpc-2637	7	42	original	original	ADJ
dpc-2637	7	43	authors	author	NOUN
dpc-2637	7	44	and	and	CCONJ
dpc-2637	7	45	source	source	NOUN
dpc-2637	7	46	are	be	AUX
dpc-2637	7	47	credited	credit	VERB
dpc-2637	7	48	.	.	PUNCT
dpc-2637	8	1	funding	funding	NOUN
dpc-2637	8	2	:	:	PUNCT
dpc-2637	8	3	none	none	NOUN
dpc-2637	8	4	.	.	PUNCT
dpc-2637	9	1	competing	compete	VERB
dpc-2637	9	2	interests	interest	NOUN
dpc-2637	9	3	:	:	PUNCT
dpc-2637	9	4	none	none	NOUN
dpc-2637	9	5	.	.	PUNCT
dpc-2637	10	1	authorship	authorship	NOUN
dpc-2637	10	2	:	:	PUNCT
dpc-2637	10	3	all	all	DET
dpc-2637	10	4	authors	author	NOUN
dpc-2637	10	5	have	have	AUX
dpc-2637	10	6	contributed	contribute	VERB
dpc-2637	10	7	significantly	significantly	ADV
dpc-2637	10	8	to	to	ADP
dpc-2637	10	9	this	this	DET
dpc-2637	10	10	publication	publication	NOUN
dpc-2637	10	11	.	.	PUNCT
dpc-2637	11	1	corresponding	correspond	VERB
dpc-2637	11	2	author	author	NOUN
dpc-2637	11	3	:	:	PUNCT
dpc-2637	11	4	maria	maria	PROPN
dpc-2637	11	5	inês	inês	PROPN
dpc-2637	11	6	alexandre	alexandre	PROPN
dpc-2637	11	7	,	,	PUNCT
dpc-2637	11	8	serviço	serviço	PROPN
dpc-2637	11	9	de	de	X
dpc-2637	11	10	endocrinologia	endocrinologia	PROPN
dpc-2637	11	11	,	,	PUNCT
dpc-2637	11	12	hospital	hospital	NOUN
dpc-2637	11	13	de	de	X
dpc-2637	11	14	santa	santa	PROPN
dpc-2637	11	15	maria	maria	PROPN
dpc-2637	11	16	,	,	PUNCT
dpc-2637	11	17	centro	centro	PROPN
dpc-2637	11	18	hospitalar	hospitalar	PROPN
dpc-2637	11	19	universitário	universitário	PROPN
dpc-2637	11	20	de	de	PROPN
dpc-2637	11	21	lisboa	lisboa	PROPN
dpc-2637	11	22	norte	norte	NOUN
dpc-2637	11	23	,	,	PUNCT
dpc-2637	11	24	1649	1649	NUM
dpc-2637	11	25	-	-	SYM
dpc-2637	11	26	028	028	NUM
dpc-2637	11	27	lisboa	lisboa	PROPN
dpc-2637	11	28	,	,	PUNCT
dpc-2637	11	29	portugal	portugal	PROPN
dpc-2637	11	30	.	.	PUNCT
dpc-2637	11	31	phone	phone	PROPN
dpc-2637	11	32	:	:	PUNCT
dpc-2637	11	33	00351	00351	NUM
dpc-2637	11	34	21	21	NUM
dpc-2637	11	35	780	780	NUM
dpc-2637	11	36	5000	5000	NUM
dpc-2637	11	37	;	;	PUNCT
dpc-2637	11	38	e	e	X
dpc-2637	11	39	-	-	NOUN
dpc-2637	11	40	mail	mail	NOUN
dpc-2637	11	41	:	:	PUNCT
dpc-2637	11	42	mariaines.f.alexandre@gmail.com	mariaines.f.alexandre@gmail.com	NOUN
dpc-2637	11	43	bullous	bullous	ADJ
dpc-2637	11	44	pemphigoid	pemphigoid	NOUN
dpc-2637	11	45	(	(	PUNCT
dpc-2637	11	46	bp	bp	PROPN
dpc-2637	11	47	)	)	PUNCT
dpc-2637	11	48	affects	affect	VERB
dpc-2637	11	49	predominantly	predominantly	ADV
dpc-2637	11	50	elderly	elderly	ADJ
dpc-2637	11	51	patients	patient	NOUN
dpc-2637	11	52	,	,	PUNCT
dpc-2637	11	53	and	and	CCONJ
dpc-2637	11	54	the	the	DET
dpc-2637	11	55	disease	disease	NOUN
dpc-2637	11	56	incidence	incidence	NOUN
dpc-2637	11	57	rises	rise	VERB
dpc-2637	11	58	exponentially	exponentially	ADV
dpc-2637	11	59	with	with	ADP
dpc-2637	11	60	age	age	NOUN
dpc-2637	11	61	.	.	PUNCT
dpc-2637	12	1	a	a	DET
dpc-2637	12	2	high	high	ADJ
dpc-2637	12	3	prevalence	prevalence	NOUN
dpc-2637	12	4	of	of	ADP
dpc-2637	12	5	diabetes	diabetes	NOUN
dpc-2637	12	6	mellitus	mellitus	NOUN
dpc-2637	12	7	(	(	PUNCT
dpc-2637	12	8	dm	dm	PROPN
dpc-2637	12	9	)	)	PUNCT
dpc-2637	12	10	in	in	ADP
dpc-2637	12	11	patients	patient	NOUN
dpc-2637	12	12	with	with	ADP
dpc-2637	12	13	bp	bp	PROPN
dpc-2637	12	14	has	have	AUX
dpc-2637	12	15	been	be	AUX
dpc-2637	12	16	noticed	notice	VERB
dpc-2637	12	17	,	,	PUNCT
dpc-2637	12	18	ranging	range	VERB
dpc-2637	12	19	from	from	ADP
dpc-2637	12	20	20	20	NUM
dpc-2637	12	21	to	to	PART
dpc-2637	12	22	30	30	NUM
dpc-2637	12	23	%	%	NOUN
dpc-2637	12	24	[	[	X
dpc-2637	12	25	1	1	NUM
dpc-2637	12	26	]	]	PUNCT
dpc-2637	12	27	.	.	PUNCT
dpc-2637	13	1	the	the	DET
dpc-2637	13	2	treatment	treatment	NOUN
dpc-2637	13	3	of	of	ADP
dpc-2637	13	4	bp	bp	PROPN
dpc-2637	13	5	patients	patient	NOUN
dpc-2637	13	6	is	be	AUX
dpc-2637	13	7	challenging	challenge	VERB
dpc-2637	13	8	and	and	CCONJ
dpc-2637	13	9	should	should	AUX
dpc-2637	13	10	be	be	AUX
dpc-2637	13	11	carefully	carefully	ADV
dpc-2637	13	12	assessed	assess	VERB
dpc-2637	13	13	bearing	bearing	NOUN
dpc-2637	13	14	in	in	ADP
dpc-2637	13	15	mind	mind	NOUN
dpc-2637	13	16	their	their	PRON
dpc-2637	13	17	multiple	multiple	ADJ
dpc-2637	13	18	comorbidities	comorbiditie	NOUN
dpc-2637	13	19	.	.	PUNCT
dpc-2637	14	1	corticosteroids	corticosteroid	NOUN
dpc-2637	14	2	are	be	AUX
dpc-2637	14	3	the	the	DET
dpc-2637	14	4	mainstay	mainstay	NOUN
dpc-2637	14	5	of	of	ADP
dpc-2637	14	6	treatment	treatment	NOUN
dpc-2637	14	7	for	for	ADP
dpc-2637	14	8	bp	bp	PROPN
dpc-2637	14	9	.	.	PUNCT
dpc-2637	15	1	however	however	ADV
dpc-2637	15	2	,	,	PUNCT
dpc-2637	15	3	their	their	PRON
dpc-2637	15	4	systemic	systemic	ADJ
dpc-2637	15	5	use	use	NOUN
dpc-2637	15	6	is	be	AUX
dpc-2637	15	7	limited	limit	VERB
dpc-2637	15	8	in	in	ADP
dpc-2637	15	9	diabetic	diabetic	ADJ
dpc-2637	15	10	patients	patient	NOUN
dpc-2637	15	11	by	by	ADP
dpc-2637	15	12	the	the	DET
dpc-2637	15	13	risk	risk	NOUN
dpc-2637	15	14	of	of	ADP
dpc-2637	15	15	acute	acute	ADJ
dpc-2637	15	16	hyperglycemic	hyperglycemic	ADJ
dpc-2637	15	17	complications	complication	NOUN
dpc-2637	15	18	.	.	PUNCT
dpc-2637	16	1	this	this	PRON
dpc-2637	16	2	is	be	AUX
dpc-2637	16	3	particularly	particularly	ADV
dpc-2637	16	4	concerning	concern	VERB
dpc-2637	16	5	given	give	VERB
dpc-2637	16	6	the	the	DET
dpc-2637	16	7	age	age	NOUN
dpc-2637	16	8	group	group	NOUN
dpc-2637	16	9	of	of	ADP
dpc-2637	16	10	bp	bp	PROPN
dpc-2637	16	11	patients	patient	NOUN
dpc-2637	16	12	and	and	CCONJ
dpc-2637	16	13	the	the	DET
dpc-2637	16	14	chronicity	chronicity	NOUN
dpc-2637	16	15	of	of	ADP
dpc-2637	16	16	treatment	treatment	NOUN
dpc-2637	16	17	.	.	PUNCT
dpc-2637	17	1	adjunctive	adjunctive	ADJ
dpc-2637	17	2	therapy	therapy	NOUN
dpc-2637	17	3	with	with	ADP
dpc-2637	17	4	immunosuppressants	immunosuppressant	NOUN
dpc-2637	17	5	such	such	ADJ
dpc-2637	17	6	as	as	ADP
dpc-2637	17	7	azathioprine	azathioprine	NOUN
dpc-2637	17	8	,	,	PUNCT
dpc-2637	17	9	mycophenolate	mycophenolate	PROPN
dpc-2637	17	10	mofetil	mofetil	NOUN
dpc-2637	17	11	or	or	CCONJ
dpc-2637	17	12	methotrexate	methotrexate	NOUN
dpc-2637	17	13	may	may	AUX
dpc-2637	17	14	also	also	ADV
dpc-2637	17	15	be	be	AUX
dpc-2637	17	16	needed	need	VERB
dpc-2637	17	17	[	[	PUNCT
dpc-2637	17	18	2	2	NUM
dpc-2637	17	19	]	]	PUNCT
dpc-2637	17	20	.	.	PUNCT
dpc-2637	18	1	also	also	ADV
dpc-2637	18	2	,	,	PUNCT
dpc-2637	18	3	novel	novel	ADJ
dpc-2637	18	4	targeted	target	VERB
dpc-2637	18	5	therapeutic	therapeutic	ADJ
dpc-2637	18	6	approaches	approach	NOUN
dpc-2637	18	7	such	such	ADJ
dpc-2637	18	8	as	as	ADP
dpc-2637	18	9	omalizumab	omalizumab	NOUN
dpc-2637	18	10	and	and	CCONJ
dpc-2637	18	11	dupilumab	dupilumab	NOUN
dpc-2637	18	12	have	have	AUX
dpc-2637	18	13	been	be	AUX
dpc-2637	18	14	reported	report	VERB
dpc-2637	18	15	as	as	ADP
dpc-2637	18	16	effective	effective	ADJ
dpc-2637	18	17	alternatives	alternative	NOUN
dpc-2637	18	18	,	,	PUNCT
dpc-2637	18	19	but	but	CCONJ
dpc-2637	18	20	their	their	PRON
dpc-2637	18	21	use	use	NOUN
dpc-2637	18	22	in	in	ADP
dpc-2637	18	23	bp	bp	PROPN
dpc-2637	18	24	is	be	AUX
dpc-2637	18	25	still	still	ADV
dpc-2637	18	26	off	off	ADP
dpc-2637	18	27	-	-	PUNCT
dpc-2637	18	28	label	label	NOUN
dpc-2637	19	1	[	[	X
dpc-2637	19	2	3	3	NUM
dpc-2637	19	3	]	]	PUNCT
dpc-2637	19	4	.	.	PUNCT
dpc-2637	20	1	several	several	ADJ
dpc-2637	20	2	population	population	NOUN
dpc-2637	20	3	-	-	PUNCT
dpc-2637	20	4	based	base	VERB
dpc-2637	20	5	studies	study	NOUN
dpc-2637	20	6	supported	support	VERB
dpc-2637	20	7	an	an	DET
dpc-2637	20	8	increased	increase	VERB
dpc-2637	20	9	risk	risk	NOUN
dpc-2637	20	10	of	of	ADP
dpc-2637	20	11	developing	develop	VERB
dpc-2637	20	12	bp	bp	PROPN
dpc-2637	20	13	in	in	ADP
dpc-2637	20	14	diabetic	diabetic	ADJ
dpc-2637	20	15	patients	patient	NOUN
dpc-2637	20	16	treated	treat	VERB
dpc-2637	20	17	with	with	ADP
dpc-2637	20	18	dipeptidyl	dipeptidyl	NOUN
dpc-2637	20	19	peptidase-4	peptidase-4	NOUN
dpc-2637	20	20	inhibitors	inhibitor	NOUN
dpc-2637	20	21	(	(	PUNCT
dpc-2637	20	22	dpp4i	dpp4i	PROPN
dpc-2637	20	23	)	)	PUNCT
dpc-2637	20	24	.	.	PUNCT
dpc-2637	21	1	a	a	DET
dpc-2637	21	2	recent	recent	ADJ
dpc-2637	21	3	meta	meta	ADJ
dpc-2637	21	4	-	-	PUNCT
dpc-2637	21	5	analysis	analysis	NOUN
dpc-2637	21	6	showed	show	VERB
dpc-2637	21	7	that	that	SCONJ
dpc-2637	21	8	the	the	DET
dpc-2637	21	9	odds	odd	NOUN
dpc-2637	21	10	ratio	ratio	NOUN
dpc-2637	21	11	(	(	PUNCT
dpc-2637	21	12	or	or	CCONJ
dpc-2637	21	13	)	)	PUNCT
dpc-2637	21	14	for	for	ADP
dpc-2637	21	15	bp	bp	PROPN
dpc-2637	21	16	among	among	ADP
dpc-2637	21	17	patients	patient	NOUN
dpc-2637	21	18	receiving	receive	VERB
dpc-2637	21	19	any	any	DET
dpc-2637	21	20	dpp4i	dpp4i	NOUN
dpc-2637	21	21	ranged	range	VERB
dpc-2637	21	22	from	from	ADP
dpc-2637	21	23	1.27	1.27	NUM
dpc-2637	21	24	to	to	ADP
dpc-2637	21	25	3.45	3.45	NUM
dpc-2637	21	26	[	[	X
dpc-2637	21	27	4	4	NUM
dpc-2637	21	28	]	]	PUNCT
dpc-2637	21	29	.	.	PUNCT
dpc-2637	22	1	the	the	DET
dpc-2637	22	2	exact	exact	ADJ
dpc-2637	22	3	pathogenesis	pathogenesis	NOUN
dpc-2637	22	4	of	of	ADP
dpc-2637	22	5	how	how	SCONJ
dpc-2637	22	6	dpp4i	dpp4i	PROPN
dpc-2637	22	7	might	might	AUX
dpc-2637	22	8	induce	induce	VERB
dpc-2637	22	9	bp	bp	PROPN
dpc-2637	22	10	remains	remain	VERB
dpc-2637	22	11	largely	largely	ADV
dpc-2637	22	12	unclear	unclear	ADJ
dpc-2637	22	13	and	and	CCONJ
dpc-2637	22	14	it	it	PRON
dpc-2637	22	15	is	be	AUX
dpc-2637	22	16	not	not	PART
dpc-2637	22	17	known	know	VERB
dpc-2637	22	18	if	if	SCONJ
dpc-2637	22	19	the	the	DET
dpc-2637	22	20	suspension	suspension	NOUN
dpc-2637	22	21	of	of	ADP
dpc-2637	22	22	dpp4i	dpp4i	PROPN
dpc-2637	22	23	can	can	AUX
dpc-2637	22	24	revert	revert	VERB
dpc-2637	22	25	this	this	DET
dpc-2637	22	26	immunological	immunological	ADJ
dpc-2637	22	27	process	process	NOUN
dpc-2637	22	28	.	.	PUNCT
dpc-2637	23	1	however	however	ADV
dpc-2637	23	2	,	,	PUNCT
dpc-2637	23	3	the	the	DET
dpc-2637	23	4	clinical	clinical	ADJ
dpc-2637	23	5	outcome	outcome	NOUN
dpc-2637	23	6	appears	appear	VERB
dpc-2637	23	7	to	to	PART
dpc-2637	23	8	be	be	AUX
dpc-2637	23	9	better	well	ADJ
dpc-2637	23	10	if	if	SCONJ
dpc-2637	23	11	dpp4i	dpp4i	PROPN
dpc-2637	23	12	is	be	AUX
dpc-2637	23	13	discontinued	discontinue	VERB
dpc-2637	23	14	.	.	PUNCT
dpc-2637	24	1	a	a	DET
dpc-2637	24	2	presumed	presume	VERB
dpc-2637	24	3	association	association	NOUN
dpc-2637	24	4	between	between	ADP
dpc-2637	24	5	bp	bp	PROPN
dpc-2637	24	6	and	and	CCONJ
dpc-2637	24	7	glucagon	glucagon	NOUN
dpc-2637	24	8	-	-	PUNCT
dpc-2637	24	9	like	like	ADJ
dpc-2637	24	10	peptide-1	peptide-1	PROPN
dpc-2637	24	11	(	(	PUNCT
dpc-2637	24	12	glp-1	glp-1	NOUN
dpc-2637	24	13	)	)	PUNCT
dpc-2637	24	14	receptor	receptor	NOUN
dpc-2637	24	15	agonists	agonist	NOUN
dpc-2637	24	16	has	have	AUX
dpc-2637	24	17	also	also	ADV
dpc-2637	24	18	been	be	AUX
dpc-2637	24	19	reported	report	VERB
dpc-2637	24	20	 	 	SPACE
dpc-2637	24	21	[	[	X
dpc-2637	24	22	5	5	NUM
dpc-2637	24	23	]	]	PUNCT
dpc-2637	24	24	.	.	PUNCT
dpc-2637	25	1	the	the	DET
dpc-2637	25	2	underlying	underlying	ADJ
dpc-2637	25	3	mechanism	mechanism	NOUN
dpc-2637	25	4	is	be	AUX
dpc-2637	25	5	unclear	unclear	ADJ
dpc-2637	25	6	,	,	PUNCT
dpc-2637	25	7	however	however	ADV
dpc-2637	25	8	since	since	SCONJ
dpc-2637	25	9	dpp4i	dpp4i	PROPN
dpc-2637	25	10	and	and	CCONJ
dpc-2637	25	11	glp-1	glp-1	PRON
dpc-2637	25	12	receptor	receptor	NOUN
dpc-2637	25	13	agonists	agonist	NOUN
dpc-2637	25	14	both	both	PRON
dpc-2637	25	15	rely	rely	VERB
dpc-2637	25	16	on	on	ADP
dpc-2637	25	17	enhancing	enhance	VERB
dpc-2637	25	18	the	the	DET
dpc-2637	25	19	activity	activity	NOUN
dpc-2637	25	20	of	of	ADP
dpc-2637	25	21	the	the	DET
dpc-2637	25	22	incretin	incretin	ADJ
dpc-2637	25	23	hormone	hormone	NOUN
dpc-2637	25	24	glp-1	glp-1	NOUN
dpc-2637	25	25	,	,	PUNCT
dpc-2637	25	26	a	a	DET
dpc-2637	25	27	common	common	ADJ
dpc-2637	25	28	effect	effect	NOUN
dpc-2637	25	29	between	between	ADP
dpc-2637	25	30	these	these	DET
dpc-2637	25	31	two	two	NUM
dpc-2637	25	32	classes	class	NOUN
dpc-2637	25	33	of	of	ADP
dpc-2637	25	34	antidiabetic	antidiabetic	ADJ
dpc-2637	25	35	drugs	drug	NOUN
dpc-2637	25	36	should	should	AUX
dpc-2637	25	37	be	be	AUX
dpc-2637	25	38	sought	seek	VERB
dpc-2637	25	39	.	.	PUNCT
dpc-2637	26	1	although	although	SCONJ
dpc-2637	26	2	more	more	ADJ
dpc-2637	26	3	robust	robust	ADJ
dpc-2637	26	4	studies	study	NOUN
dpc-2637	26	5	are	be	AUX
dpc-2637	26	6	required	require	VERB
dpc-2637	26	7	,	,	PUNCT
dpc-2637	26	8	we	we	PRON
dpc-2637	26	9	suggest	suggest	VERB
dpc-2637	26	10	that	that	SCONJ
dpc-2637	26	11	this	this	DET
dpc-2637	26	12	association	association	NOUN
dpc-2637	26	13	is	be	AUX
dpc-2637	26	14	taken	take	VERB
dpc-2637	26	15	into	into	ADP
dpc-2637	26	16	account	account	NOUN
dpc-2637	26	17	when	when	SCONJ
dpc-2637	26	18	selecting	select	VERB
dpc-2637	26	19	the	the	DET
dpc-2637	26	20	most	most	ADV
dpc-2637	26	21	appropriate	appropriate	ADJ
dpc-2637	26	22	medication	medication	NOUN
dpc-2637	26	23	for	for	ADP
dpc-2637	26	24	bp	bp	PROPN
dpc-2637	26	25	patients	patient	NOUN
dpc-2637	26	26	.	.	PUNCT
dpc-2637	27	1	other	other	ADJ
dpc-2637	27	2	widely	widely	ADV
dpc-2637	27	3	used	use	VERB
dpc-2637	27	4	antidiabetic	antidiabetic	ADJ
dpc-2637	27	5	drugs	drug	NOUN
dpc-2637	27	6	like	like	ADP
dpc-2637	27	7	second	second	ADJ
dpc-2637	27	8	-	-	PUNCT
dpc-2637	27	9	generation	generation	NOUN
dpc-2637	27	10	sulfonylureas	sulfonylurea	NOUN
dpc-2637	27	11	and	and	CCONJ
dpc-2637	27	12	metformin	metformin	NOUN
dpc-2637	27	13	seem	seem	VERB
dpc-2637	27	14	safer	safe	ADJ
dpc-2637	27	15	options	option	NOUN
dpc-2637	27	16	,	,	PUNCT
dpc-2637	27	17	but	but	CCONJ
dpc-2637	27	18	their	their	PRON
dpc-2637	27	19	use	use	NOUN
dpc-2637	27	20	can	can	AUX
dpc-2637	27	21	be	be	AUX
dpc-2637	27	22	limited	limit	VERB
dpc-2637	27	23	by	by	ADP
dpc-2637	27	24	the	the	DET
dpc-2637	27	25	patient	patient	NOUN
dpc-2637	27	26	’s	’s	PART
dpc-2637	27	27	comorbidities	comorbiditie	NOUN
dpc-2637	28	1	[	[	X
dpc-2637	28	2	6	6	NUM
dpc-2637	28	3	]	]	PUNCT
dpc-2637	28	4	.	.	PUNCT
dpc-2637	29	1	the	the	DET
dpc-2637	29	2	sodium	sodium	NOUN
dpc-2637	29	3	–	–	PUNCT
dpc-2637	29	4	glucose	glucose	NOUN
dpc-2637	29	5	cotransporter	cotransporter	NOUN
dpc-2637	29	6	(	(	PUNCT
dpc-2637	29	7	sglt)2	sglt)2	NOUN
dpc-2637	29	8	inhibitors	inhibitor	NOUN
dpc-2637	29	9	also	also	ADV
dpc-2637	29	10	seem	seem	VERB
dpc-2637	29	11	like	like	ADP
dpc-2637	29	12	good	good	ADJ
dpc-2637	29	13	alternatives	alternative	NOUN
dpc-2637	29	14	.	.	PUNCT
dpc-2637	30	1	these	these	DET
dpc-2637	30	2	drugs	drug	NOUN
dpc-2637	30	3	do	do	AUX
dpc-2637	30	4	not	not	PART
dpc-2637	30	5	increase	increase	VERB
dpc-2637	30	6	the	the	DET
dpc-2637	30	7	risk	risk	NOUN
dpc-2637	30	8	of	of	ADP
dpc-2637	30	9	hypoglycemia	hypoglycemia	NOUN
dpc-2637	30	10	,	,	PUNCT
dpc-2637	30	11	have	have	VERB
dpc-2637	30	12	low	low	ADJ
dpc-2637	30	13	rates	rate	NOUN
dpc-2637	30	14	of	of	ADP
dpc-2637	30	15	adverse	adverse	ADJ
dpc-2637	30	16	effects	effect	NOUN
dpc-2637	30	17	and	and	CCONJ
dpc-2637	30	18	may	may	AUX
dpc-2637	30	19	be	be	AUX
dpc-2637	30	20	continued	continue	VERB
dpc-2637	30	21	in	in	ADP
dpc-2637	30	22	patients	patient	NOUN
dpc-2637	30	23	with	with	ADP
dpc-2637	30	24	moderate	moderate	ADJ
dpc-2637	30	25	renal	renal	ADJ
dpc-2637	30	26	impairment	impairment	NOUN
dpc-2637	30	27	.	.	PUNCT
dpc-2637	31	1	overall	overall	ADV
dpc-2637	31	2	,	,	PUNCT
dpc-2637	31	3	they	they	PRON
dpc-2637	31	4	can	can	AUX
dpc-2637	31	5	be	be	AUX
dpc-2637	31	6	used	use	VERB
dpc-2637	31	7	in	in	ADP
dpc-2637	31	8	selected	select	VERB
dpc-2637	31	9	bp	bp	PROPN
dpc-2637	31	10	patients	patient	NOUN
dpc-2637	31	11	.	.	PUNCT
dpc-2637	32	1	2	2	NUM
dpc-2637	32	2	commentary	commentary	NOUN
dpc-2637	32	3	|	|	ADV
dpc-2637	32	4	dermatol	dermatol	ADJ
dpc-2637	32	5	pract	pract	NOUN
dpc-2637	32	6	concept	concept	NOUN
dpc-2637	32	7	.	.	PUNCT
dpc-2637	33	1	2023;13(1):e2023063	2023;13(1):e2023063	NUM
dpc-2637	33	2	in	in	ADP
dpc-2637	33	3	many	many	ADJ
dpc-2637	33	4	cases	case	NOUN
dpc-2637	33	5	,	,	PUNCT
dpc-2637	33	6	insulin	insulin	NOUN
dpc-2637	33	7	is	be	AUX
dpc-2637	33	8	the	the	DET
dpc-2637	33	9	most	most	ADV
dpc-2637	33	10	suitable	suitable	ADJ
dpc-2637	33	11	choice	choice	NOUN
dpc-2637	33	12	,	,	PUNCT
dpc-2637	33	13	particularly	particularly	ADV
dpc-2637	33	14	for	for	ADP
dpc-2637	33	15	inpatients	inpatient	NOUN
dpc-2637	33	16	on	on	ADP
dpc-2637	33	17	corticosteroids	corticosteroid	NOUN
dpc-2637	33	18	.	.	PUNCT
dpc-2637	34	1	morning	morning	NOUN
dpc-2637	34	2	basal	basal	PROPN
dpc-2637	34	3	insulin	insulin	NOUN
dpc-2637	34	4	may	may	AUX
dpc-2637	34	5	closely	closely	ADV
dpc-2637	34	6	fit	fit	VERB
dpc-2637	34	7	the	the	DET
dpc-2637	34	8	glucose	glucose	NOUN
dpc-2637	34	9	excursion	excursion	NOUN
dpc-2637	34	10	induced	induce	VERB
dpc-2637	34	11	by	by	ADP
dpc-2637	34	12	a	a	DET
dpc-2637	34	13	single	single	ADJ
dpc-2637	34	14	dose	dose	NOUN
dpc-2637	34	15	of	of	ADP
dpc-2637	34	16	morning	morning	NOUN
dpc-2637	34	17	corticosteroid	corticosteroid	NOUN
dpc-2637	34	18	.	.	PUNCT
dpc-2637	35	1	the	the	DET
dpc-2637	35	2	initial	initial	ADJ
dpc-2637	35	3	dose	dose	NOUN
dpc-2637	35	4	and	and	CCONJ
dpc-2637	35	5	titration	titration	NOUN
dpc-2637	35	6	should	should	AUX
dpc-2637	35	7	take	take	VERB
dpc-2637	35	8	into	into	ADP
dpc-2637	35	9	account	account	NOUN
dpc-2637	35	10	the	the	DET
dpc-2637	35	11	patient	patient	NOUN
dpc-2637	35	12	’s	’s	PART
dpc-2637	35	13	weight	weight	NOUN
dpc-2637	35	14	and	and	CCONJ
dpc-2637	35	15	dose	dose	VERB
dpc-2637	35	16	of	of	ADP
dpc-2637	35	17	corticosteroid	corticosteroid	NOUN
dpc-2637	35	18	.	.	PUNCT
dpc-2637	36	1	dairy	dairy	NOUN
dpc-2637	36	2	adjustments	adjustment	NOUN
dpc-2637	36	3	are	be	AUX
dpc-2637	36	4	frequently	frequently	ADV
dpc-2637	36	5	necessary	necessary	ADJ
dpc-2637	36	6	and	and	CCONJ
dpc-2637	36	7	often	often	ADV
dpc-2637	36	8	difficult	difficult	ADJ
dpc-2637	36	9	to	to	PART
dpc-2637	36	10	predict	predict	VERB
dpc-2637	36	11	.	.	PUNCT
dpc-2637	37	1	based	base	VERB
dpc-2637	37	2	on	on	ADP
dpc-2637	37	3	the	the	DET
dpc-2637	37	4	previous	previous	ADJ
dpc-2637	37	5	data	datum	NOUN
dpc-2637	37	6	,	,	PUNCT
dpc-2637	37	7	a	a	DET
dpc-2637	37	8	treatment	treatment	NOUN
dpc-2637	37	9	algorithm	algorithm	NOUN
dpc-2637	37	10	for	for	ADP
dpc-2637	37	11	bp	bp	PROPN
dpc-2637	37	12	patients	patient	NOUN
dpc-2637	37	13	with	with	ADP
dpc-2637	37	14	type	type	NOUN
dpc-2637	37	15	2	2	NUM
dpc-2637	37	16	dm	dm	NOUN
dpc-2637	37	17	is	be	AUX
dpc-2637	37	18	proposed	propose	VERB
dpc-2637	37	19	in	in	ADP
dpc-2637	37	20	fig	fig	NOUN
dpc-2637	37	21	.	.	PUNCT
dpc-2637	38	1	1	1	X
dpc-2637	38	2	.	.	X
dpc-2637	38	3	in	in	ADP
dpc-2637	38	4	conclusion	conclusion	NOUN
dpc-2637	38	5	,	,	PUNCT
dpc-2637	38	6	it	it	PRON
dpc-2637	38	7	is	be	AUX
dpc-2637	38	8	decisive	decisive	ADJ
dpc-2637	38	9	that	that	SCONJ
dpc-2637	38	10	we	we	PRON
dpc-2637	38	11	view	view	VERB
dpc-2637	38	12	bp	bp	PROPN
dpc-2637	38	13	patients	patient	NOUN
dpc-2637	38	14	beyond	beyond	ADP
dpc-2637	38	15	a	a	DET
dpc-2637	38	16	single	single	ADJ
dpc-2637	38	17	-	-	PUNCT
dpc-2637	38	18	disease	disease	NOUN
dpc-2637	38	19	framework	framework	NOUN
dpc-2637	38	20	and	and	CCONJ
dpc-2637	38	21	treat	treat	VERB
dpc-2637	38	22	them	they	PRON
dpc-2637	38	23	in	in	ADP
dpc-2637	38	24	the	the	DET
dpc-2637	38	25	context	context	NOUN
dpc-2637	38	26	of	of	ADP
dpc-2637	38	27	multi	multi	NOUN
dpc-2637	38	28	-	-	NOUN
dpc-2637	38	29	morbidities	morbidity	NOUN
dpc-2637	38	30	.	.	PUNCT
dpc-2637	39	1	diabetes	diabetes	NOUN
dpc-2637	39	2	management	management	NOUN
dpc-2637	39	3	in	in	ADP
dpc-2637	39	4	these	these	DET
dpc-2637	39	5	patients	patient	NOUN
dpc-2637	39	6	can	can	AUX
dpc-2637	39	7	be	be	AUX
dpc-2637	39	8	particularly	particularly	ADV
dpc-2637	39	9	troublesome	troublesome	ADJ
dpc-2637	39	10	and	and	CCONJ
dpc-2637	39	11	,	,	PUNCT
dpc-2637	39	12	to	to	ADP
dpc-2637	39	13	date	date	NOUN
dpc-2637	39	14	,	,	PUNCT
dpc-2637	39	15	there	there	PRON
dpc-2637	39	16	are	be	VERB
dpc-2637	39	17	no	no	DET
dpc-2637	39	18	orienting	orient	VERB
dpc-2637	39	19	guidelines	guideline	NOUN
dpc-2637	39	20	on	on	ADP
dpc-2637	39	21	this	this	DET
dpc-2637	39	22	matter	matter	NOUN
dpc-2637	39	23	.	.	PUNCT
dpc-2637	40	1	endocrinologists	endocrinologist	NOUN
dpc-2637	40	2	should	should	AUX
dpc-2637	40	3	be	be	AUX
dpc-2637	40	4	aware	aware	ADJ
dpc-2637	40	5	of	of	ADP
dpc-2637	40	6	bp	bp	PROPN
dpc-2637	40	7	as	as	ADP
dpc-2637	40	8	a	a	DET
dpc-2637	40	9	challenging	challenging	ADJ
dpc-2637	40	10	problem	problem	NOUN
dpc-2637	40	11	in	in	ADP
dpc-2637	40	12	patients	patient	NOUN
dpc-2637	40	13	with	with	ADP
dpc-2637	40	14	dm	dm	NOUN
dpc-2637	40	15	and	and	CCONJ
dpc-2637	40	16	collaboration	collaboration	NOUN
dpc-2637	40	17	with	with	ADP
dpc-2637	40	18	dermatologists	dermatologist	NOUN
dpc-2637	40	19	is	be	AUX
dpc-2637	40	20	essential	essential	ADJ
dpc-2637	40	21	for	for	ADP
dpc-2637	40	22	good	good	ADJ
dpc-2637	40	23	outcomes	outcome	NOUN
dpc-2637	40	24	.	.	PUNCT
dpc-2637	41	1	references	reference	NOUN
dpc-2637	41	2	1	1	NUM
dpc-2637	41	3	.	.	PUNCT
dpc-2637	41	4	chai	chai	PROPN
dpc-2637	41	5	zt	zt	PROPN
dpc-2637	41	6	,	,	PUNCT
dpc-2637	41	7	tan	tan	PROPN
dpc-2637	41	8	c	c	NOUN
dpc-2637	41	9	,	,	PUNCT
dpc-2637	41	10	meiqi	meiqi	PROPN
dpc-2637	41	11	liau	liau	PROPN
dpc-2637	41	12	m	m	PROPN
dpc-2637	41	13	,	,	PUNCT
dpc-2637	41	14	et	et	PROPN
dpc-2637	41	15	al	al	PROPN
dpc-2637	41	16	.	.	PROPN
dpc-2637	42	1	diabetes	diabete	VERB
dpc-2637	42	2	mellitus	mellitus	NOUN
dpc-2637	42	3	and	and	CCONJ
dpc-2637	42	4	hyperglycemic	hyperglycemic	ADJ
dpc-2637	42	5	complications	complication	NOUN
dpc-2637	42	6	in	in	ADP
dpc-2637	42	7	bullous	bullous	ADJ
dpc-2637	42	8	pemphigoid	pemphigoid	NOUN
dpc-2637	42	9	.	.	PUNCT
dpc-2637	43	1	j	j	PROPN
dpc-2637	43	2	am	be	AUX
dpc-2637	43	3	acad	acad	ADJ
dpc-2637	43	4	dermatol	dermatol	NOUN
dpc-2637	43	5	.	.	PUNCT
dpc-2637	44	1	2020	2020	NUM
dpc-2637	45	1	may;82(5):1234	may;82(5):1234	PROPN
dpc-2637	45	2	-	-	PUNCT
dpc-2637	45	3	1237	1237	NUM
dpc-2637	45	4	.	.	PUNCT
dpc-2637	46	1	2	2	X
dpc-2637	46	2	.	.	X
dpc-2637	46	3	di	di	PROPN
dpc-2637	46	4	lernia	lernia	PROPN
dpc-2637	46	5	v	v	PROPN
dpc-2637	46	6	,	,	PUNCT
dpc-2637	46	7	casanova	casanova	X
dpc-2637	46	8	dm	dm	PROPN
dpc-2637	46	9	,	,	PUNCT
dpc-2637	46	10	goldust	goldust	PROPN
dpc-2637	46	11	m	m	PROPN
dpc-2637	46	12	,	,	PUNCT
dpc-2637	46	13	ricci	ricci	PROPN
dpc-2637	46	14	c.	c.	PROPN
dpc-2637	46	15	pemphigus	pemphigus	PROPN
dpc-2637	46	16	vulgaris	vulgaris	PROPN
dpc-2637	46	17	and	and	CCONJ
dpc-2637	46	18	bullous	bullous	ADJ
dpc-2637	46	19	pemphigoid	pemphigoid	NOUN
dpc-2637	46	20	:	:	PUNCT
dpc-2637	46	21	update	update	NOUN
dpc-2637	46	22	on	on	ADP
dpc-2637	46	23	diagnosis	diagnosis	NOUN
dpc-2637	46	24	and	and	CCONJ
dpc-2637	46	25	treatment	treatment	NOUN
dpc-2637	46	26	.	.	PUNCT
dpc-2637	47	1	dermatol	dermatol	NOUN
dpc-2637	47	2	pract	pract	PROPN
dpc-2637	47	3	concept	concept	NOUN
dpc-2637	47	4	.	.	PUNCT
dpc-2637	48	1	2020	2020	NUM
dpc-2637	48	2	jun	jun	PROPN
dpc-2637	48	3	29;10(3):e2020050	29;10(3):e2020050	NUM
dpc-2637	48	4	.	.	PUNCT
dpc-2637	49	1	3	3	X
dpc-2637	49	2	.	.	X
dpc-2637	49	3	garrido	garrido	PROPN
dpc-2637	49	4	pm	pm	PROPN
dpc-2637	49	5	,	,	PUNCT
dpc-2637	49	6	alexandre	alexandre	PROPN
dpc-2637	49	7	mi	mi	PROPN
dpc-2637	49	8	,	,	PUNCT
dpc-2637	49	9	travassos	travassos	PROPN
dpc-2637	49	10	ar	ar	PROPN
dpc-2637	49	11	,	,	PUNCT
dpc-2637	49	12	filipe	filipe	PROPN
dpc-2637	49	13	p.	p.	PROPN
dpc-2637	49	14	dipeptidyl	dipeptidyl	NOUN
dpc-2637	49	15	-	-	PUNCT
dpc-2637	49	16	peptidase	peptidase	NOUN
dpc-2637	49	17	iv	iv	NUM
dpc-2637	49	18	inhibitor	inhibitor	NOUN
dpc-2637	49	19	-	-	PUNCT
dpc-2637	49	20	associated	associate	VERB
dpc-2637	49	21	bullous	bullous	ADJ
dpc-2637	49	22	pemphigoid	pemphigoid	ADJ
dpc-2637	49	23	type	type	NOUN
dpc-2637	49	24	2	2	NUM
dpc-2637	49	25	dm	dm	NOUN
dpc-2637	49	26	with	with	ADP
dpc-2637	49	27	bp	bp	PROPN
dpc-2637	49	28	consider	consider	VERB
dpc-2637	49	29	discontinuation	discontinuation	NOUN
dpc-2637	49	30	of	of	ADP
dpc-2637	49	31	dpp4i	dpp4i	PROPN
dpc-2637	49	32	,	,	PUNCT
dpc-2637	49	33	if	if	SCONJ
dpc-2637	49	34	present	present	ADJ
dpc-2637	49	35	if	if	SCONJ
dpc-2637	49	36	patient	patient	ADJ
dpc-2637	49	37	is	be	AUX
dpc-2637	49	38	treated	treat	VERB
dpc-2637	49	39	with	with	ADP
dpc-2637	49	40	systemic	systemic	ADJ
dpc-2637	49	41	corticosteroids	corticosteroid	NOUN
dpc-2637	49	42	consider	consider	VERB
dpc-2637	49	43	referral	referral	ADJ
dpc-2637	49	44	to	to	ADP
dpc-2637	49	45	an	an	DET
dpc-2637	49	46	endocrinologist	endocrinologist	NOUN
dpc-2637	49	47	if	if	SCONJ
dpc-2637	49	48	glycemia	glycemia	NOUN
dpc-2637	49	49	is	be	AUX
dpc-2637	49	50	persistently	persistently	ADV
dpc-2637	49	51	above	above	ADP
dpc-2637	49	52	200	200	NUM
dpc-2637	49	53	mg	mg	PROPN
dpc-2637	49	54	/	/	SYM
dpc-2637	49	55	dl	dl	PROPN
dpc-2637	49	56	insulintreated	insulintreate	VERB
dpc-2637	49	57	patients	patient	NOUN
dpc-2637	49	58	non	non	ADJ
dpc-2637	49	59	-	-	ADJ
dpc-2637	49	60	insulintreated	insulintreated	ADJ
dpc-2637	49	61	patients	patient	NOUN
dpc-2637	49	62	morning	morning	NOUN
dpc-2637	49	63	basal	basal	VERB
dpc-2637	49	64	insulin	insulin	NOUN
dpc-2637	49	65	0,2	0,2	NUM
dpc-2637	49	66	u	u	NOUN
dpc-2637	49	67	/	/	SYM
dpc-2637	49	68	kg	kg	PROPN
dpc-2637	49	69	/	/	SYM
dpc-2637	49	70	day	day	NOUN
dpc-2637	49	71	(	(	PUNCT
dpc-2637	49	72	ex	ex	NOUN
dpc-2637	49	73	:	:	PUNCT
dpc-2637	49	74	glargin	glargin	VERB
dpc-2637	49	75	/	/	SYM
dpc-2637	49	76	nph	nph	NOUN
dpc-2637	49	77	)	)	PUNCT
dpc-2637	49	78	increase	increase	NOUN
dpc-2637	49	79	basal	basal	ADJ
dpc-2637	49	80	insulin	insulin	NOUN
dpc-2637	49	81	2u	2u	NOUN
dpc-2637	49	82	every	every	DET
dpc-2637	49	83	2	2	NUM
dpc-2637	49	84	-	-	SYM
dpc-2637	49	85	3	3	NUM
dpc-2637	49	86	days	day	NOUN
dpc-2637	49	87	if	if	SCONJ
dpc-2637	49	88	glycemia	glycemia	NOUN
dpc-2637	49	89	before	before	ADP
dpc-2637	49	90	dinner	dinner	NOUN
dpc-2637	49	91	is	be	AUX
dpc-2637	49	92	above	above	ADP
dpc-2637	49	93	180	180	NUM
dpc-2637	49	94	mg	mg	PROPN
dpc-2637	49	95	/	/	SYM
dpc-2637	49	96	dl	dl	PROPN
dpc-2637	49	97	after	after	ADP
dpc-2637	49	98	discharge	discharge	NOUN
dpc-2637	49	99	,	,	PUNCT
dpc-2637	49	100	return	return	VERB
dpc-2637	49	101	to	to	ADP
dpc-2637	49	102	oral	oral	ADJ
dpc-2637	49	103	antidiabetic	antidiabetic	ADJ
dpc-2637	49	104	drugs	drug	NOUN
dpc-2637	49	105	if	if	SCONJ
dpc-2637	49	106	possible	possible	ADJ
dpc-2637	49	107	(	(	PUNCT
dpc-2637	49	108	see	see	VERB
dpc-2637	49	109	outpatient	outpatient	NOUN
dpc-2637	49	110	care	care	NOUN
dpc-2637	49	111	scheme	scheme	NOUN
dpc-2637	49	112	)	)	PUNCT
dpc-2637	49	113	;	;	PUNCT
dpc-2637	49	114	evaluate	evaluate	VERB
dpc-2637	49	115	need	need	NOUN
dpc-2637	49	116	to	to	PART
dpc-2637	49	117	maintain	maintain	VERB
dpc-2637	49	118	basal	basal	ADJ
dpc-2637	49	119	insulin	insulin	NOUN
dpc-2637	49	120	pre	pre	ADJ
dpc-2637	49	121	-	-	ADJ
dpc-2637	49	122	prandial	prandial	ADJ
dpc-2637	49	123	rapid	rapid	ADJ
dpc-2637	49	124	/	/	SYM
dpc-2637	49	125	short	short	ADJ
dpc-2637	49	126	action	action	NOUN
dpc-2637	49	127	insulin	insulin	NOUN
dpc-2637	49	128	according	accord	VERB
dpc-2637	49	129	to	to	ADP
dpc-2637	49	130	glycemia	glycemia	NOUN
dpc-2637	49	131	(	(	PUNCT
dpc-2637	49	132	ex	ex	NOUN
dpc-2637	49	133	:	:	PUNCT
dpc-2637	49	134	<	<	X
dpc-2637	49	135	140	140	NUM
dpc-2637	49	136	mg	mg	PROPN
dpc-2637	49	137	/	/	SYM
dpc-2637	49	138	dl	dl	PROPN
dpc-2637	49	139	:	:	PUNCT
dpc-2637	49	140	ou	ou	PROPN
dpc-2637	49	141	;	;	PUNCT
dpc-2637	49	142	140	140	NUM
dpc-2637	49	143	-	-	PUNCT
dpc-2637	49	144	200mg	200mg	NUM
dpc-2637	49	145	/	/	SYM
dpc-2637	49	146	dl	dl	PROPN
dpc-2637	49	147	:	:	PUNCT
dpc-2637	49	148	2u	2u	NOUN
dpc-2637	49	149	;	;	PUNCT
dpc-2637	49	150	201	201	NUM
dpc-2637	49	151	-	-	PUNCT
dpc-2637	49	152	250mg	250mg	NOUN
dpc-2637	49	153	/	/	SYM
dpc-2637	49	154	dl	dl	PROPN
dpc-2637	49	155	:	:	PUNCT
dpc-2637	49	156	4u	4u	NOUN
dpc-2637	49	157	;	;	PUNCT
dpc-2637	49	158	251	251	NUM
dpc-2637	49	159	-	-	PUNCT
dpc-2637	49	160	300mg	300mg	NOUN
dpc-2637	49	161	/	/	SYM
dpc-2637	49	162	dl	dl	NOUN
dpc-2637	49	163	:	:	PUNCT
dpc-2637	49	164	6u	6u	NUM
dpc-2637	49	165	;	;	PUNCT
dpc-2637	49	166	301	301	NUM
dpc-2637	49	167	-	-	PUNCT
dpc-2637	49	168	350mg	350mg	NOUN
dpc-2637	49	169	/	/	SYM
dpc-2637	49	170	dl	dl	PROPN
dpc-2637	49	171	:	:	PUNCT
dpc-2637	49	172	8u	8u	NUM
dpc-2637	49	173	;	;	PUNCT
dpc-2637	49	174	351	351	NUM
dpc-2637	49	175	-	-	PUNCT
dpc-2637	49	176	400mg	400mg	NOUN
dpc-2637	49	177	/	/	SYM
dpc-2637	49	178	dl	dl	NOUN
dpc-2637	49	179	:	:	PUNCT
dpc-2637	49	180	10u	10u	NOUN
dpc-2637	49	181	;	;	PUNCT
dpc-2637	49	182	401	401	NUM
dpc-2637	49	183	-	-	PUNCT
dpc-2637	49	184	450mg	450mg	PROPN
dpc-2637	49	185	/	/	SYM
dpc-2637	49	186	dl	dl	PROPN
dpc-2637	49	187	:	:	PUNCT
dpc-2637	49	188	12u	12u	NUM
dpc-2637	49	189	;	;	PUNCT
dpc-2637	49	190	≥451mg	≥451mg	NUM
dpc-2637	49	191	/	/	SYM
dpc-2637	49	192	dl	dl	NOUN
dpc-2637	49	193	:	:	PUNCT
dpc-2637	49	194	14u	14u	NUM
dpc-2637	49	195	)	)	PUNCT
dpc-2637	49	196	switch	switch	NOUN
dpc-2637	49	197	to	to	ADP
dpc-2637	49	198	basal	basal	PROPN
dpc-2637	49	199	morning	morning	NOUN
dpc-2637	49	200	administration	administration	NOUN
dpc-2637	49	201	and	and	CCONJ
dpc-2637	49	202	consider	consider	VERB
dpc-2637	49	203	increase	increase	NOUN
dpc-2637	49	204	dose	dose	VERB
dpc-2637	49	205	in	in	ADP
dpc-2637	49	206	10	10	NUM
dpc-2637	49	207	-	-	SYM
dpc-2637	49	208	20	20	NUM
dpc-2637	49	209	%	%	NOUN
dpc-2637	49	210	.	.	PUNCT
dpc-2637	50	1	if	if	SCONJ
dpc-2637	50	2	ambulatory	ambulatory	ADJ
dpc-2637	50	3	dose	dose	NOUN
dpc-2637	50	4	is	be	AUX
dpc-2637	50	5	not	not	PART
dpc-2637	50	6	known	know	VERB
dpc-2637	50	7	start	start	NOUN
dpc-2637	50	8	at	at	ADP
dpc-2637	50	9	0,3	0,3	NUM
dpc-2637	50	10	-	-	PUNCT
dpc-2637	50	11	0,4	0,4	NUM
dpc-2637	50	12	u	u	NOUN
dpc-2637	50	13	/	/	SYM
dpc-2637	50	14	kg	kg	ADJ
dpc-2637	50	15	/	/	SYM
dpc-2637	50	16	day	day	NOUN
dpc-2637	50	17	increase	increase	NOUN
dpc-2637	50	18	basal	basal	VERB
dpc-2637	50	19	insulin	insulin	NOUN
dpc-2637	50	20	2u	2u	NOUN
dpc-2637	50	21	every	every	DET
dpc-2637	50	22	2	2	NUM
dpc-2637	50	23	-	-	SYM
dpc-2637	50	24	3	3	NUM
dpc-2637	50	25	days	day	NOUN
dpc-2637	50	26	if	if	SCONJ
dpc-2637	50	27	glycemia	glycemia	NOUN
dpc-2637	50	28	before	before	ADP
dpc-2637	50	29	dinner	dinner	NOUN
dpc-2637	50	30	is	be	AUX
dpc-2637	50	31	above	above	ADP
dpc-2637	50	32	180	180	NUM
dpc-2637	50	33	mg	mg	PROPN
dpc-2637	50	34	/	/	SYM
dpc-2637	50	35	dl	dl	PROPN
dpc-2637	50	36	check	check	NOUN
dpc-2637	50	37	glycemia	glycemia	NOUN
dpc-2637	50	38	at	at	ADP
dpc-2637	50	39	admission	admission	NOUN
dpc-2637	50	40	and	and	CCONJ
dpc-2637	50	41	every	every	DET
dpc-2637	50	42	4	4	NUM
dpc-2637	50	43	hours	hour	NOUN
dpc-2637	50	44	inpatient	inpatient	PROPN
dpc-2637	50	45	care	care	NOUN
dpc-2637	50	46	outpatient	outpatient	NOUN
dpc-2637	50	47	care	care	NOUN
dpc-2637	50	48	advise	advise	VERB
dpc-2637	50	49	to	to	PART
dpc-2637	50	50	check	check	VERB
dpc-2637	50	51	glycemia	glycemia	NOUN
dpc-2637	50	52	before	before	SCONJ
dpc-2637	50	53	every	every	DET
dpc-2637	50	54	meal	meal	NOUN
dpc-2637	50	55	optimize	optimize	NOUN
dpc-2637	50	56	metformin	metformin	NOUN
dpc-2637	50	57	dose	dose	NOUN
dpc-2637	50	58	if	if	SCONJ
dpc-2637	50	59	tolerated	tolerate	VERB
dpc-2637	50	60	and	and	CCONJ
dpc-2637	50	61	patient	patient	NOUN
dpc-2637	50	62	’s	’s	PART
dpc-2637	50	63	egfr>30	egfr>30	PROPN
dpc-2637	50	64	ml	ml	AUX
dpc-2637	50	65	/	/	SYM
dpc-2637	50	66	min/1.72m2	min/1.72m2	PROPN
dpc-2637	50	67	consider	consider	VERB
dpc-2637	50	68	adding	add	VERB
dpc-2637	50	69	sglt2i	sglt2i	NOUN
dpc-2637	50	70	(	(	PUNCT
dpc-2637	50	71	adjustments	adjustment	NOUN
dpc-2637	50	72	may	may	AUX
dpc-2637	50	73	be	be	AUX
dpc-2637	50	74	needed	need	VERB
dpc-2637	50	75	for	for	ADP
dpc-2637	50	76	renal	renal	ADJ
dpc-2637	50	77	impairment	impairment	NOUN
dpc-2637	50	78	;	;	PUNCT
dpc-2637	50	79	see	see	VERB
dpc-2637	50	80	drug	drug	NOUN
dpc-2637	50	81	information	information	NOUN
dpc-2637	50	82	)	)	PUNCT
dpc-2637	50	83	sulfonylureas	sulfonylureas	PROPN
dpc-2637	50	84	(	(	PUNCT
dpc-2637	50	85	later	later	ADV
dpc-2637	50	86	generation	generation	NOUN
dpc-2637	50	87	)	)	PUNCT
dpc-2637	50	88	also	also	ADV
dpc-2637	50	89	an	an	DET
dpc-2637	50	90	option	option	NOUN
dpc-2637	50	91	;	;	PUNCT
dpc-2637	50	92	higher	high	ADJ
dpc-2637	50	93	risk	risk	NOUN
dpc-2637	50	94	of	of	ADP
dpc-2637	50	95	hypoglycemia	hypoglycemia	NOUN
dpc-2637	50	96	avoid	avoid	VERB
dpc-2637	50	97	dpp4i	dpp4i	ADP
dpc-2637	50	98	combination	combination	NOUN
dpc-2637	50	99	/	/	SYM
dpc-2637	50	100	mono	mono	NOUN
dpc-2637	50	101	therapy	therapy	NOUN
dpc-2637	50	102	caution	caution	NOUN
dpc-2637	50	103	with	with	ADP
dpc-2637	50	104	glp1a	glp1a	PROPN
dpc-2637	50	105	morning	morning	NOUN
dpc-2637	50	106	basal	basal	PROPN
dpc-2637	50	107	insulin	insulin	NOUN
dpc-2637	50	108	may	may	AUX
dpc-2637	50	109	be	be	AUX
dpc-2637	50	110	needed	need	VERB
dpc-2637	50	111	if	if	SCONJ
dpc-2637	50	112	glycemia	glycemia	NOUN
dpc-2637	50	113	is	be	AUX
dpc-2637	50	114	above	above	ADP
dpc-2637	50	115	180	180	NUM
dpc-2637	50	116	mg	mg	PROPN
dpc-2637	50	117	/	/	SYM
dpc-2637	50	118	dl	dl	PROPN
dpc-2637	50	119	before	before	ADP
dpc-2637	50	120	dinner	dinner	NOUN
dpc-2637	50	121	figure	figure	NOUN
dpc-2637	50	122	1	1	NUM
dpc-2637	50	123	.	.	PUNCT
dpc-2637	50	124	proposed	propose	VERB
dpc-2637	50	125	treatment	treatment	NOUN
dpc-2637	50	126	algorithm	algorithm	NOUN
dpc-2637	50	127	for	for	ADP
dpc-2637	50	128	bullous	bullous	ADJ
dpc-2637	50	129	pemphigoid	pemphigoid	ADJ
dpc-2637	50	130	patients	patient	NOUN
dpc-2637	50	131	with	with	ADP
dpc-2637	50	132	type	type	NOUN
dpc-2637	50	133	2	2	NUM
dpc-2637	50	134	diabetes	diabetes	NOUN
dpc-2637	50	135	mellitus	mellitus	NOUN
dpc-2637	50	136	treated	treat	VERB
dpc-2637	50	137	with	with	ADP
dpc-2637	50	138	corticosteroids	corticosteroid	NOUN
dpc-2637	50	139	.	.	PUNCT
dpc-2637	51	1	bp	bp	PROPN
dpc-2637	51	2	,	,	PUNCT
dpc-2637	51	3	bullous	bullous	ADJ
dpc-2637	51	4	pemphigoid	pemphigoid	NOUN
dpc-2637	51	5	;	;	PUNCT
dpc-2637	51	6	dm	dm	NUM
dpc-2637	51	7	,	,	PUNCT
dpc-2637	51	8	diabetes	diabetes	NOUN
dpc-2637	51	9	mellitus	mellitus	NOUN
dpc-2637	51	10	;	;	PUNCT
dpc-2637	51	11	dpp4i	dpp4i	CCONJ
dpc-2637	51	12	,	,	PUNCT
dpc-2637	51	13	dipeptidyl	dipeptidyl	ADJ
dpc-2637	51	14	peptidase-4	peptidase-4	X
dpc-2637	51	15	inhibitor	inhibitor	NOUN
dpc-2637	51	16	;	;	PUNCT
dpc-2637	51	17	egfr	egfr	X
dpc-2637	51	18	,	,	PUNCT
dpc-2637	51	19	estimated	estimate	VERB
dpc-2637	51	20	glomerular	glomerular	ADJ
dpc-2637	51	21	filtration	filtration	NOUN
dpc-2637	51	22	rate	rate	NOUN
dpc-2637	51	23	;	;	PUNCT
dpc-2637	51	24	glp1a	glp1a	PROPN
dpc-2637	51	25	,	,	PUNCT
dpc-2637	51	26	glucagon	glucagon	NOUN
dpc-2637	51	27	-	-	PUNCT
dpc-2637	51	28	like	like	ADJ
dpc-2637	51	29	peptide	peptide	NOUN
dpc-2637	51	30	1	1	NUM
dpc-2637	51	31	receptor	receptor	NOUN
dpc-2637	51	32	agonist	agonist	NOUN
dpc-2637	51	33	;	;	PUNCT
dpc-2637	51	34	sglt2i	sglt2i	PROPN
dpc-2637	51	35	,	,	PUNCT
dpc-2637	51	36	sodium	sodium	NOUN
dpc-2637	51	37	–	–	PUNCT
dpc-2637	51	38	glucose	glucose	NOUN
dpc-2637	51	39	cotransporter	cotransporter	NOUN
dpc-2637	51	40	2	2	NUM
dpc-2637	51	41	inhibitor	inhibitor	NOUN
dpc-2637	51	42	.	.	PUNCT
dpc-2637	52	1	commentary	commentary	NOUN
dpc-2637	52	2	|	|	ADV
dpc-2637	52	3	dermatol	dermatol	ADJ
dpc-2637	52	4	pract	pract	NOUN
dpc-2637	52	5	concept	concept	NOUN
dpc-2637	52	6	.	.	PUNCT
dpc-2637	53	1	2023;13(1):e2023063	2023;13(1):e2023063	NUM
dpc-2637	53	2	3	3	NUM
dpc-2637	53	3	efficiently	efficiently	ADV
dpc-2637	53	4	treated	treat	VERB
dpc-2637	53	5	with	with	ADP
dpc-2637	53	6	omalizumab	omalizumab	NOUN
dpc-2637	53	7	.	.	PUNCT
dpc-2637	54	1	dermatol	dermatol	NOUN
dpc-2637	54	2	ther	ther	ADV
dpc-2637	54	3	.	.	PUNCT
dpc-2637	55	1	2020	2020	NUM
dpc-2637	55	2	nov;33(6):e14160	nov;33(6):e14160	NOUN
dpc-2637	55	3	.	.	PUNCT
dpc-2637	56	1	4	4	X
dpc-2637	56	2	.	.	X
dpc-2637	56	3	kridin	kridin	VERB
dpc-2637	56	4	k	k	PROPN
dpc-2637	56	5	,	,	PUNCT
dpc-2637	56	6	cohen	cohen	PROPN
dpc-2637	56	7	ad	ad	NOUN
dpc-2637	56	8	.	.	PUNCT
dpc-2637	57	1	dipeptidyl	dipeptidyl	NOUN
dpc-2637	57	2	-	-	PUNCT
dpc-2637	57	3	peptidase	peptidase	NOUN
dpc-2637	57	4	iv	iv	NUM
dpc-2637	57	5	inhibitor	inhibitor	NOUN
dpc-2637	57	6	-	-	PUNCT
dpc-2637	57	7	associated	associate	VERB
dpc-2637	57	8	bullous	bullous	ADJ
dpc-2637	57	9	pemphigoid	pemphigoid	NOUN
dpc-2637	57	10	:	:	PUNCT
dpc-2637	57	11	a	a	DET
dpc-2637	57	12	systematic	systematic	ADJ
dpc-2637	57	13	review	review	NOUN
dpc-2637	57	14	and	and	CCONJ
dpc-2637	57	15	meta	meta	ADJ
dpc-2637	57	16	-	-	PUNCT
dpc-2637	57	17	analysis	analysis	NOUN
dpc-2637	57	18	.	.	PUNCT
dpc-2637	58	1	j	j	PROPN
dpc-2637	58	2	am	be	AUX
dpc-2637	58	3	acad	acad	ADJ
dpc-2637	58	4	dermatol	dermatol	NOUN
dpc-2637	58	5	.	.	PUNCT
dpc-2637	59	1	2021	2021	NUM
dpc-2637	59	2	aug;85(2):501	aug;85(2):501	NUM
dpc-2637	59	3	-	-	SYM
dpc-2637	59	4	503	503	NUM
dpc-2637	59	5	.	.	NOUN
dpc-2637	60	1	5	5	NUM
dpc-2637	60	2	.	.	X
dpc-2637	60	3	burruss	burruss	PROPN
dpc-2637	60	4	cp	cp	PROPN
dpc-2637	60	5	,	,	PUNCT
dpc-2637	60	6	jones	jones	PROPN
dpc-2637	60	7	jm	jm	PROPN
dpc-2637	60	8	,	,	PUNCT
dpc-2637	60	9	burruss	burruss	PROPN
dpc-2637	60	10	jb	jb	PROPN
dpc-2637	60	11	.	.	PUNCT
dpc-2637	60	12	semaglutide	semaglutide	ADV
dpc-2637	60	13	-	-	PUNCT
dpc-2637	60	14	associated	associate	VERB
dpc-2637	60	15	bullous	bullous	ADJ
dpc-2637	60	16	pemphigoid	pemphigoid	NOUN
dpc-2637	60	17	.	.	PUNCT
dpc-2637	61	1	jaad	jaad	NOUN
dpc-2637	61	2	case	case	NOUN
dpc-2637	61	3	rep	rep	PROPN
dpc-2637	61	4	.	.	PROPN
dpc-2637	61	5	2021	2021	NUM
dpc-2637	61	6	aug	aug	PROPN
dpc-2637	61	7	5;15:107	5;15:107	PROPN
dpc-2637	61	8	-	-	SYM
dpc-2637	61	9	109	109	NUM
dpc-2637	61	10	.	.	NOUN
dpc-2637	61	11	6	6	NUM
dpc-2637	61	12	.	.	X
dpc-2637	61	13	lee	lee	PROPN
dpc-2637	61	14	h	h	PROPN
dpc-2637	61	15	,	,	PUNCT
dpc-2637	61	16	chung	chung	PROPN
dpc-2637	61	17	hj	hj	PROPN
dpc-2637	61	18	,	,	PUNCT
dpc-2637	61	19	pawar	pawar	PROPN
dpc-2637	61	20	a	a	PROPN
dpc-2637	61	21	,	,	PUNCT
dpc-2637	61	22	patorno	patorno	PROPN
dpc-2637	61	23	e	e	PROPN
dpc-2637	61	24	,	,	PUNCT
dpc-2637	61	25	kim	kim	PROPN
dpc-2637	61	26	dh	dh	PROPN
dpc-2637	61	27	.	.	PUNCT
dpc-2637	62	1	evaluation	evaluation	NOUN
dpc-2637	62	2	of	of	ADP
dpc-2637	62	3	risk	risk	NOUN
dpc-2637	62	4	of	of	ADP
dpc-2637	62	5	bullous	bullous	ADJ
dpc-2637	62	6	pemphigoid	pemphigoid	NOUN
dpc-2637	62	7	with	with	ADP
dpc-2637	62	8	initiation	initiation	NOUN
dpc-2637	62	9	of	of	ADP
dpc-2637	62	10	dipeptidyl	dipeptidyl	NOUN
dpc-2637	62	11	peptidase-4	peptidase-4	NOUN
dpc-2637	62	12	inhibitor	inhibitor	NOUN
dpc-2637	62	13	vs	vs	ADP
dpc-2637	62	14	second	second	ADJ
dpc-2637	62	15	-	-	PUNCT
dpc-2637	62	16	generation	generation	NOUN
dpc-2637	62	17	sulfonylurea	sulfonylurea	NOUN
dpc-2637	62	18	.	.	PUNCT
dpc-2637	63	1	jama	jama	PROPN
dpc-2637	63	2	dermatol	dermatol	NOUN
dpc-2637	63	3	.	.	PUNCT
dpc-2637	64	1	2020	2020	NUM
dpc-2637	64	2	oct	oct	PROPN
dpc-2637	64	3	1;156(10):1107	1;156(10):1107	PROPN
dpc-2637	64	4	-	-	SYM
dpc-2637	64	5	1114	1114	NUM
dpc-2637	64	6	.	.	PUNCT